Compare WOLF & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WOLF | AVNS |
|---|---|---|
| Founded | 1987 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 505.2M | 521.7M |
| IPO Year | 2025 | 2014 |
| Metric | WOLF | AVNS |
|---|---|---|
| Price | $18.36 | $13.87 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $12.75 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 583.8K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.59 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,385,982,000.00 | $701,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.10 | $4.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 19.00 | 1.95 |
| 52 Week Low | $0.39 | $9.30 |
| 52 Week High | $36.60 | $15.68 |
| Indicator | WOLF | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 50.36 | 51.35 |
| Support Level | $16.64 | $10.94 |
| Resistance Level | $19.15 | $15.68 |
| Average True Range (ATR) | 1.61 | 0.53 |
| MACD | -0.23 | -0.10 |
| Stochastic Oscillator | 35.75 | 47.95 |
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.